XML 59 R41.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Schedule of Income Before Income Taxes
 
    
Year ended December 31,
 
    
2021
    
2020
    
2019
 
    
(U.S. $ in millions)
 
Parent Company and its Israeli subsidiaries
   $ 126      $ 947      $ 542  
Non-Israeli subsidiaries
     532        (5,353      (1,807
    
 
 
    
 
 
    
 
 
 
     $ 658      $ (4,406    $ (1,265
    
 
 
    
 
 
    
 
 
 
Schedule of the Provision for Income Taxes
b.
Income taxes:
 
    
Year ended December 31,
 
    
2021
    
2020
    
2019
 
    
(U.S. $ in millions)
 
In Israel
   $ 124      $ 60      $ 107  
Outside Israel
     87        (228      (385
    
 
 
    
 
 
    
 
 
 
     $ 211      $ (168    $ (278
    
 
 
    
 
 
    
 
 
 
Current
   $ 270      $ 182      $ 885  
Deferred
     (59      (350      (1,163
    
 
 
    
 
 
    
 
 
 
     $ 211      $ (168    $ (278
    
 
 
    
 
 
    
 
 
 
Accumulated Other Comprehensive Income/(Loss) (Net of Tax)
 
  
2021
 
 
2020
 
 
2019
 
 
  
(U.S. $ in millions)
 
Income (loss) before income taxes
   $ 658     $ (4,406   $ (1,265
Statutory tax rate in Israel
     23     23     23
    
 
 
   
 
 
   
 
 
 
Theoretical provision for income taxes
   $ 151     $ (1,013   $ (291
Increase (decrease) in the provision for income taxes due to:
                        
The Parent Company and its Israeli subsidiaries - Tax benefits arising from reduced tax rates under benefit programs
     (12     (153     (77
Mainly nondeductible items and prior year tax
     20      
(30
)
   
33
 
Non-Israeli subsidiaries, including impairments (*)
     117       1,369       (115
Increase (decrease) in other uncertain tax positions—net
     (65     (341     172  
    
 
 
   
 
 
   
 
 
 
Effective consolidated income taxes
   $ 211     $ (168   $ (278
    
 
 
   
 
 
   
 
 
 
 
(*)
In 2020, income before income taxes includes goodwill impairment in non-Israeli subsidiaries that did not have a corresponding tax effect.
Schedule of Deferred Income Taxes
c.
Deferred income taxes:
 
    
December 31,
 
    
2021
    
2020
 
    
(U.S. $ in millions)
 
Deferred tax assets (liabilities), net:
        
Inventory related
   $ 104      $ 212  
Sales reserves and allowances
     136        173  
Provision for legal settlements
     360        235  
Intangible assets (*)
     (814      (1,064
Carryforward losses and deductions and credits (**)
     2,093        2,176  
Property, plant and equipment
     (215      (142
Deferred interest
     617        527  
Provisions for employee related obligations
     95        107  
Other
     159        54  
    
 
 
    
 
 
 
       2,535        2,278  
Valuation allowance—in respect of carryforward losses and deductions that may not be
utilized
     (2,723      (2,547
    
 
 
    
 
 
 
     $ (188    $ (269
    
 
 
    
 
 
 
 
(*)
The decrease in deferred tax liability is mainly due to impairment and amortization.
(**)
The amounts are shown following a reduction for unrecognized tax benefits of $10 million and $63 million as of December 31, 2021 and 2020, respectively.
Schedule of Deferred Tax Assets and Liabilities By Report Caption
The deferred income taxes are reflected in the balance sheets among:
 
    
December 31,
 
    
2021
    
2020
 
    
(U.S. $ in millions)
 
Long-term assets—deferred income taxes
     596        695  
Long-term liabilities—deferred income taxes
     (784      (964
    
 
 
    
 
 
 
     $ (188    $ (269
    
 
 
    
 
 
 
Schedule of Unrecognized Tax Benefits
The following table summarizes the activity of Teva’s gross unrecognized tax benefits:
 
    
Year ended December 31,
 
    
2021
    
2020
    
2019
 
    
(U.S. $ in millions)
 
Balance at the beginning of the year
   $ 888      $ 1,223      $ 1,072  
Increase (decrease) related to prior year tax positions, net
     (106      (238      23  
Increase related to current year tax positions
     7        10        246  
Decrease related to settlements with tax authorities and lapse of applicable statutes of limitations
     (115      (105      (118
Other
     (2      (2      —    
    
 
 
    
 
 
    
 
 
 
Balance at the end of the year
   $ 672      $ 888      $ 1,223